576 related articles for article (PubMed ID: 26246459)
1. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK; ; ;
Diabetes Care; 2015 Sep; 38(9):1777-803. PubMed ID: 26246459
[TBL] [Abstract][Full Text] [Related]
2. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK;
Circulation; 2015 Aug; 132(8):691-718. PubMed ID: 26246173
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
Avogaro A
G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
[TBL] [Abstract][Full Text] [Related]
4. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
Circulation; 2019 Sep; 140(11):e563-e595. PubMed ID: 30879339
[TBL] [Abstract][Full Text] [Related]
5. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
Circulation; 2019 Sep; 140(11):e596-e646. PubMed ID: 30879355
[No Abstract] [Full Text] [Related]
6. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
Joseph JJ; Deedwania P; Acharya T; Aguilar D; Bhatt DL; Chyun DA; Di Palo KE; Golden SH; Sperling LS;
Circulation; 2022 Mar; 145(9):e722-e759. PubMed ID: 35000404
[TBL] [Abstract][Full Text] [Related]
8. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
Cho L; Davis M; Elgendy I; Epps K; Lindley KJ; Mehta PK; Michos ED; Minissian M; Pepine C; Vaccarino V; Volgman AS;
J Am Coll Cardiol; 2020 May; 75(20):2602-2618. PubMed ID: 32439010
[TBL] [Abstract][Full Text] [Related]
9. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
Gilpin VL; ; ;
J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
[No Abstract] [Full Text] [Related]
10. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; Piña IL;
Circulation; 2019 Aug; 140(7):e294-e324. PubMed ID: 31167558
[TBL] [Abstract][Full Text] [Related]
11. Preventing CVD in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA.
Hauk L
Am Fam Physician; 2016 Feb; 93(3):232-3. PubMed ID: 26926617
[No Abstract] [Full Text] [Related]
12. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Smith SC; Blair SN; Bonow RO; Brass LM; Cerqueira MD; Dracup K; Fuster V; Gotto A; Grundy SM; Miller NH; Jacobs A; Jones D; Krauss RM; Mosca L; Ockene I; Pasternak RC; Pearson T; Pfeffer MA; Starke RD; Taubert KA
J Am Coll Cardiol; 2001 Nov; 38(5):1581-3. PubMed ID: 11691544
[No Abstract] [Full Text] [Related]
13. AHA and ACC issue scientific statement on preventive cardiology for women. American Heart Association and American College of Cardiology.
Rose VL
Am Fam Physician; 1999 Oct; 60(6):1846. PubMed ID: 10537392
[No Abstract] [Full Text] [Related]
14. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
Lund SS; Vaag AA
Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
[No Abstract] [Full Text] [Related]
15. The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.
Bittner V
Circulation; 2020 Dec; 142(25):2402-2404. PubMed ID: 30879338
[No Abstract] [Full Text] [Related]
16. [Polish forum for prevention guidelines on cardiovascular risk assessment].
Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
[No Abstract] [Full Text] [Related]
17. Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis.
Han X; Fox DS; Chu M; Dougherty JS; McCombs J
J Manag Care Spec Pharm; 2018 Nov; 24(11):1078-1085. PubMed ID: 30362921
[TBL] [Abstract][Full Text] [Related]
18. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
Matthys F; De Backer T; De Backer G; Stichele RV
Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
[TBL] [Abstract][Full Text] [Related]
19. [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.].
Armario P; Brotons C; Elosua R; Alonso de Leciñana M; Castro A; Clarà A; Cortés O; Díaz Rodriguez Á; Herranz M; Justo S; Lahoz C; Pedro-Botet J; Pérez Pérez A; Santamaria R; Tresserras R; Aznar Lain S; Royo-Bordonada MÁ
Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32915170
[TBL] [Abstract][Full Text] [Related]
20. [Interpretation of 2019 American College of Cardiology/American Heart Association guidelines on the primary prevention of cardiovascular disease].
Zhang XF; Hu DY
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):259-263. PubMed ID: 32209189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
